Market Research Blog

[250 Pages Report] As per comprehensive research conducted by ESOMAR-certified consulting firm FMI, the global Transcatheter Heart Valve Replacement (TAVI) market is projected to witness robust growth during the forecast year 2021-2031. The report emphasizes on providing key insights into diverse features including demand, product developments, revenue generation, and sales in the Transcatheter Heart Valve Replacement (TAVI) market.

The study offers a detailed analysis of dynamics including driver, restraints, opportunities, and challenges, and also highlights their consequent impact on the market.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-537

Advent of Telehealth and Virtual Care to Create Tailwind for the Transcatheter Heart Valve Replacement (TAVI) Market Growth

Digitization is making deeper inroads across diverse industries, such as healthcare, owing to the increasing penetration of the internet and smartphones across the world.

During the COVID-19 outbreak, healthcare practitioners and patients realized the importance of digitization and encouraged them to adopt virtual methods of patient examination and consultation to counter the regulations concerning social distancing. This gave rise to a new medical domain, Telehealth.

Since the outbreak, telehealth have gained immense popularity, especially among the geriatric population, owing to the convenience associated with it. Hence, increasing adoption of telehealth across radiology, behavioral health, cardiology, and online consultation is expected to create lucrative opportunities for growth in the Transcatheter Heart Valve Replacement (TAVI) market.

Key Transcatheter Heart Valve Replacement (TAVI) Market Takeaways and Projections

• The U.S. is estimated to continue dominating the North America market, projecting fastest growth in the region through 2031.
• Germany Transcatheter Heart Valve Replacement (TAVI) market is forecast to register robust growth in Europe, accounting for a significant share in the region between 2021 and 2031.
• China is expected to account for the maximum revenue share in the East Asia market, exhibiting the fastest sales growth during the assessment period.
• India is forecast to emerge as a highly remunerative market in South Asia, contributing for the largest sales in the region over the coming 10-years.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-537

Report Benefits & Key Questions Answered

• Transcatheter Heart Valve Replacement (TAVI) Historical Market Outlook: Future Market Insight’s analysis examines vital dynamics, such as drivers, opportunities, and challenges in the Transcatheter Heart Valve Replacement (TAVI) market. It also studies the impact of these dynamics on the market for the previous assessment period 2016-2020 to forecast the scope of market growth over the coming forecast period 2021-2031.
• Transcatheter Heart Valve Replacement (TAVI) Demand-Supply Assessment: The latest study published by FMI offers in-depth insights into governing factors facilitating the demand outlook of the Transcatheter Heart Valve Replacement (TAVI) market. As per the survey, Transcatheter Heart Valve Replacement (TAVI) sales will project steady growth over the forecast period.
• Transcatheter Heart Valve Replacement (TAVI) Market Structure Analysis: The report provides detailed information about market the concentration of key players and tier analysis in the Transcatheter Heart Valve Replacement (TAVI) market. It also categories market players as per Tier 1, Tier 2, and Tier 3 in terms of their percentage share and product portfolio.
• Transcatheter Heart Valve Replacement (TAVI) Category & Segment Level Analysis: FMI’s category & segment level analysis provides insights into key factors affecting the market growth across various segments in terms of (segment 1), (segment 2), and (segment 3). It also uncovers critical opportunities across each segment to assist key players to capitalize on the,
• Transcatheter Heart Valve Replacement (TAVI) Market Trend Analysis: FMI’s market trend analysis provide compelling insights into current and upcoming trends in the healthcare industries. It also assists the industry players to identify potential trends to formulate a strategy to take advantage of these existing trends.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-537

Competitive Landscape Analysis

The latest study conducted by FMI provides in-depth insights into the global Transcatheter Heart Valve Replacement (TAVI) market to assist management level decision-makers in constructing a strategy to capitalize on the critical trends & opportunities. It also discloses competitive trends and profiles a list of leading players operating in the global Transcatheter Heart Valve Replacement (TAVI) market.

Scope Of Report

Report Attribute	Details
Growth rate	CAGR of 12% from 2022 to 2032
Base year for estimation	2021
Historical data	2015 – 2020
Forecast period	2022 – 2032
Quantitative units	Revenue in USD Million, volume in kilotons, and CAGR from 2022 to 2032
Report coverage	Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,
Segments covered	Product, Surgical Approach, Application, Region
Regional scope	North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand
Country scope	U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Key companies profiled	Abbott, HighLife Medical, 4C Medical Technologies, JC Medical, LivaNova, Boston Scientific, Edwards Lifesciences, Medtronic plc, and Neovasc
Customization scope	Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

 

[311 Pages Report] The extracorporeal membrane oxygenation systems market is progressing steadily with a CAGR of 5% from 2022-2032, as per the extracorporeal membrane oxygenation systems market analysis by Future Market Insights (FMI).

Recent developments in extracorporeal membrane oxygenation systems market innovations such as miniaturization of ECMO components like hollow pumps, which are used in various surgeries, aids in the transportation of critically ill patients, thereby increasing the ECOM systems market size.

As per the ECOM systems market study, the rising use of ECMO has sparked technological advancements in extracorporeal membrane oxygenation machines of which oxygenators and heparin-coated cannulas are two major emerging trends in the ECOM systems market.

The study finds that extracorporeal membrane oxygenation devices are used in life-threatening situations when other forms of supportive care have failed. Furthermore, the use of ECMO in various healthcare settings has increased significantly owing to its wide range of applications.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14300

The adoption of ECMO procedures is being promoted by several government organizations. One of them is GOLD (Global Initiative for Chronic Obstructive Lung Disease), a campaign that aims to raise awareness about COPD and its treatment, which includes the use of ECMO oxygen machine thereby positively influencing the ECMO systems adoption trends.

The sudden spike in COVID-19 cases, combined with an increase in the number of critically ill patients requiring additional life support, has pushed up demand for ECMO machines. For patients with severe acute respiratory distress syndrome, extracorporeal membrane oxygenation therapy has been the preferred treatment option.

An increasing number of supportive government policies and the rapid FDA approval of extracorporeal membrane oxygenation equipment for emergency use have significantly increased the ECOM systems market opportunities.

Moreover, several companies are scaling up ECOM systems’ market share by expanding their manufacturing capabilities to meet the rising demand for assistive technologies.

On account of the factors mentioned above, the ECOM systems market is predicted to muster a revenue of about US$ 673 Mn by 2026.

Key Takeaways:

• By application, high demand for early diagnosis and diagnostic imaging, and technological advancements in the extracorporeal membrane oxygenation machine market are expected to propel the respiratory segment to the top.
• The arterio-venous segment is likely to hold the majority of the market based on modality owing to the benefits associated with this technology segment, such as effective dynamic range, thereby boosting the ECMO systems market growth.
• Based on patient type, the adult segment is projected to lead the market as the global burden of cardiac and respiratory diseases in adults is rising due to increased consumption of alcohol, tobacco, smoking, and a sedentary lifestyle.
• Based on components, the controller’s segment is expected to dominate the market, and the same can be credited to the systems’ higher adoption among end-users as a result of their lower cost when compared to others.
• The portable ECMO machine segment is expected to dominate the market by product type. They are lightweight and portable, allowing them to be transported to any desired location, influencing the ECMO systems market future trends.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-14300

“North American market is anticipated to be at the forefront of the ECMO systems market because of the presence of key players and the rising number of product launches, government support for high-quality healthcare which is also considered to be a few crucial ECMO systems market trends and the rising prevalence of diseases in the United States and Canada, such as chronic obstructive pulmonary disease resulting in increased hospital admission favoured by reimbursement policies, is expected to boost the sales of ECMO systems in this region.” asserts an FMI analyst.

Competitive Landscape:Companies like Abbott Laboratories, Medtronic, Alung Technologies, and Terumo Corporation dominate the global market.

Major global players produce the majority of ECMO support systems. Market leaders have established their position by investing more in research and having a better distribution system.

To stay competitive in the market, extracorporeal membrane oxygenation machines manufacturers are actively involved in product launches and technological innovation.

• ALung Technologies, Inc. has begun commercialization of its ground-breaking next-generation artificial lung. The device is based on University of Pittsburgh intellectual property licensed to ALung Technologies, Inc.
• Medtronic has released its artificial lung therapy for the treatment of COVID-19. An artificial pump that pumps blood from a person’s body to an oxygenator is called ECMO, and it also has an FDA-approved device for ECMO procedures lasting up to 6 hours.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-14300

Key Segments By Product:

• ECMO Machines
  • Portable Devices
  • Static Devices
• Software

By Service Type:

• Application
• Middleware
• Infrastructure

By Component:

• Pumps
• Oxygenators
• Controllers
• Cannul
• Assessories

By Modality:

• Veno-Venous
• Veno-Arterials
• Arterio-Venous

By Patient Type:

• Neonates
• Pediatrics
• Adults

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

 

In terms of value, an impressive 6.4% CAGR is estimated for the global spinal cord stimulators market by a report of Future Market Insights (FMI). In 2017, the market will account for nearly US$ 2,000 Mn in revenues; by 2027 this number is estimated to reach US$ 3,568.2 Mn. Growth of the market is primarily attributed to under penetration of potential market.

Introduction of affordable devices would pave huge opportunities for the global spinal cord stimulators market across developing economies. Customized spinal cord stimulators as per the requirements of an individual is expected to offer higher growth potential for leading market players. Specialists in healthcare settings are more likely to prescribe devices that are smaller in size, owing to their easy implantation and less painful surgical procedure.

Request Sample @– https://www.futuremarketinsights.com/reports/sample/rep-gb-2030

Spinal Cord Stimulators’ Ability of Reducing Opioid Analgesics Addiction to Drive the Market Growth

Majority of patients with chronic pain are increasingly depending upon opioid analgesics; however spinal cord stimulators is capable of reducing this addiction to a great extent. Entry of additional competitors in the market is expected to increase awareness about effectiveness of spinal cord stimulators. Spinal cord stimulators are comparatively more cost-effective than conventional medical management (CMM). Leading companies in the market are taking initiatives in improving technology for spinal cord stimulators. The aforementioned factors are estimated to drive growth of the global spinal cord stimulators market.

However, spinal cord stimulators have little access to evidence-based data in order to confirm effectiveness of these devices for management of chronic pain. Clinical validation of spinal cord stimulation is based on observational data, instead of verified data. This had led several private insurance companies to refuse reimbursement of costs, which in turn is impeding the market growth. In addition, complications associated with spinal cord stimulators, such as paresthesia- characterised by burning sensation, is further expected to restrain growth of the global spinal cord stimulators market.

Rechargeable Spinal Cord Stimulators will Remain Sought-After Product in the Market

In terms of value, rechargeable spinal cord stimulators are expected to remain sought-after product in the market. Revenues amassed from sales of rechargeable spinal cord stimulators are expected to reach US$ 2,530.4 Mn by 2027-end. In addition, sales of non-rechargeable spinal cord stimulators are anticipated to expand at 4.6% CAGR through 2027. Factors such as low battery life, and requirement of surgery for replacement of battery are restricting adoption of non-rechargeable spinal cord stimulators across the globe.

Application of spinal cord stimulators will remain highest in failed back surgery syndrome (FBSS), with sales estimated to surpass US$ 1,000 Mn in 2017. In addition, complex regional pain syndrome (CRPS) is projected to be the second-fastest growing application of spinal cord stimulators in the market. In terms of value, sales of spinal cord stimulators in CRPS are estimated to register 5.8% CAGR through 2027.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2030

Adoption of Spinal Cord Stimulators to Witness Fastest Growth in Ambulatory Surgical Centres

Although hospitals will continue to be largest end-users of spinal cord stimulators, adoption will witness fastest growth in ambulatory surgical centres. Sales of spinal cord stimulators in hospitals are estimated to account for revenues worth US$ 627.9 Mn in 2017. Demand for spinal cord stimulators in ambulatory surgical centres is projected to exhibit 6.8% CAGR through 2027. In contrast, demand for spinal cord stimulators in clinics will remain sluggish in the market.

North America will continue to remain dominant in the global spinal cord stimulators market, with sales estimated to reach nearly US$ 3,000 Mn in revenues by 2027-end. Western Europe will remain the second-largest market for spinal cord stimulators, expanding at 6.1% CAGR through 2027. In addition, markets in Eastern Europe and Japan are estimated to exhibit parallel expansion at 6% CAGR through 2027.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2030

Key market players identified in FMI’s report include

• Boston Scientific Corp.
• Medtronic Private Limited Company
• St Jude Medical LLC
• Nevro Corp
• Nuvectra Corporation
• Stimwave
• Saluda Medical PTY Limited.

Spinal Cord Stimulators Market TaxonomyRegion

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• MEA
• Japan

End User

• Hospitals
• Ambulatory Surgical Units
• Clinics

Application

• Failed Back Surgery Syndrome
• Complex Regional Pain Syndrome
• Ischemic Limb Pain
• Others

Product Type

• Rechargeable
• Non-Rechargeable

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

 

[280 Pages Report] ESOMAR-certified consulting firm Future Market Insights (FMI) in its latest report forecasts that the global branded generics market will register healthy growth at a CAGR of 5.8% between 2021 and 2031.

The swift growth of branded generics market can be attributed to the growing number of patent expiry of branded or blockbuster drugs along with increasing prevalence of chronic diseases. Rising demand for cheap medical treatments is positively impacting the demand in the market.

Branded generics are pharmaceutical drugs that have been re-released with a different brand name. They are used to treat various diseases such as diabetes, hypertension, back pain and others. These drugs occupy small but lucrative subset of the entire generic market

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1260

Since branded generics are free from patenting, companies are investing handsome amounts on this drug category. The market is set to reach a valuation of around 283.2 Bn in 2021, with top players in tier-1 accounting for 20%-25% market share.

The entry of new players, simple market authorization procedures, greater profit margin and off-invoice discounts will expand branded generics market during the forecast period.

As per the FMI’s analysis, despite the slight setback due to the pandemic, the global branded generics market registered year-on-year (Y-o-Y) growth at 4.9% CAGR during 2020-2021.

“Rising demand for branded generics across both developing and developed economies along with high penetration of pharmaceutical industry will offer lucrative growth opportunities for the branded generics manufacturers during the forecast period” says the FMI analyst.

Key Takeaways from FMI’s Branded Generics Market Study

• China and India are spearheading the growth of Asia Pacific market spurred by the increasing adoption of branded generics by large-scale pharmacy chains in the emerging economies
• The U.S. will lead the North America’s branded generics market, registering a growth at 3.83% CAGR during the forecast period.
• The market in India is expected to offer lucrative growth opportunities to branded generics manufacturers backed the expansion of pharmaceutical industry
• In terms of therapeutic application, cardiovascular diseases and diabetes are expected to account for considerable market share
• Oral solid dose pharmaceutical formulation continues to be highly preferred among patients. The oral segment accounts for over 55% share of the global branded generics market.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1260

Competitive Landscape

Teva, Abbott Laboratories, Novartis, Mylan, Pfizer are some prominent players operating in the branded generics market cumulatively hold around 20-25% market share.

Key players operating in branded generic market are focusing on expanding their business in emerging markets. They are adopting various organic and inorganic growth strategies such as mergers and acquisitions, advanced product development and collaborations to gain a competitive edge in the market.

• In October 2020, Glenmark Pharmaceuticals, introduces NINDANIB (Nintedanib) for the treatment of pulmonary fibrosis in India. Glenmark has been amongst the first to launch the branded generic version at an affordable cost for the treatment of pulmonary fibrosis in India.

More Valuable Insights on Branded Generics Market

In its latest report, FMI provides an incisive coverage on the global branded generics market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031.The study provides compelling insights on branded generics market on the basis of therapeutic application (oncology, cardiovascular diseases, diabetes, neurology, gastro intestinal diseases, dermatology diseases, analgesic and others), drug class (alkylating agents, anti-metabolites, hormones, anti-hypertensives, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptics and others ), formulation type (oral, parenteral, topical, others) and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, drug stores) across seven major regions.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1260

Branded Generics Market by Category Therapeutic Application:

• Oncology
• Cardiovascular Diseases
• Diabetes
• Neurology
• Gastrointestinal Diseases
• Dermatology Diseases
• Analgesics and Anti-inflammatory
• Others

Drug Class:

• Alkylating Agents
• Antimetabolites
• Hormones
• Anti-Hypertensive
• Lipid Lowering Drugs
• Anti-Depressants
• Anti-Psychotics
• Anti-Epileptics
• Others

Formulation Type:

• Oral
• Parenteral
• Topical
• Others

Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

 

The market for revision knee replacements is expected to reach $1.3 billion by 2022. The revision knee replacement market is expected to reach $2 billion by 2032, with a CAGR of 4.1 percent.

Revision knee replacement also known as revision total knee arthroplasty, is a procedure in which already implanted artificial knee joint, or prosthesis is replaced with a new prosthesis. Revision knee replacement also include the use of bone grafts. The bone graft can be an autograft which is taken from the site in patient’s body or allograft where the bone tissue comes from donor.

There are three major purpose of revision knee replacement: relieving pain in the affected area, restoring the mobility of the patient, and removing loose or damaged prosthesis. Total knee replacement surgery is most successful but over time if the fails due to various reasons then revision knee replacement is done. Revision knee replacement have the same goal to relive pain and improve function like the total knee replacement surgery.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5966 

Revision knee replacement surgeries are more complex and take longer time and extensive planning and specialized implants and tools are required to achieve better results. There are various type of revision surgery. In certain cases only on implants or component is replaced. Other time all the three component- tibia, femoral and patellar needs to be replaced and the bone around the knee needs to rebuild with the metal piece or bone graft.

The major step in revision surgery is the removal of the old femoral component. After the removal of the metal shell in the femoral, damaged bone is scraped off and the femur bone is reshaped. If the bone is weak, the cavity inside the femur is filled with bone grafts.

Revision Knee Replacement Market: Drivers and Restraints

The revision knee replacement  is expected to grow due to the increasing rate of old age diseases like obesity arthritis, sports related injuries, osteoporosis, diabetes and aging population and. However existing and upcoming advancement in the technology in the revision knee replacement such as minimally invasive surgery and better implant materials are the factors that drive the revision knee replacement market globally.

Increasing investment in the healthcare sector also drive the market of the revision knee replacement market. Despite the widely used procedures for curing disease the global revision knee replacement market is facing challenge such as economic slowdown which is forcing patients to reconsider elective surgeries when the conservative medical treatments such as viscosupplementation may ease the pain. High cost surgery, growing awareness for the non-surgical treatment methods such as exercise, walking aids, and weight loss inhibits the market of the revision knee replacement market.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-5966 

Revision Knee Replacement Market: Overview

Revision knee replacement market is one of the most effective and widely used to relive the pain of arteritis. Technological advancement in the knee replacement market such as minimally invasive implant materials and their success rate allowing even the younger generation to undergo revision knee replacement.

The revision knee replacement promotes technologies such as 3D printed knee implants. The emerging revision knee replacement market due to advancement in the technologies and new product launch. The manufacturing companies are raising their respective market share with the help of marketing activities and growing awareness among the people.

Revision Knee Replacement Market: Regional Outlook

The market for limb correction system are examined across the region such as North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominates the revision knee replacement market due to high patient awareness, increasing healthcare expenditure and relatively larger number of research and development increase in the advancement in the technology which contribute to the revenue generation from the region.

Asia Pacific is expected to grow owing to the increasing prevalence and rapid booming medical tourism industry in the emerging economics of India and China propel the growth of the revision knee replacement market.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/5966

Revision Knee Replacement Market: Key Players

Some of the key players in the Revision Knee Replacement Market are Smith & Nephew Plc, Wright Medical Group, Inc, Zimmer Holdings, Biomet, Inc., Exactech, Stryker Corporation, DePuy Companies, Inc , B. Braun Melsungen AG, DJO Global, Ortho Development, Limacorporate S.p.a., SURGIVAL INTERNATIONAL, BEZNOSKA, s.r.o., whereas some and regional players also have a significant presence in revision knee replacement market.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Revision Knee Replacement Market: Segmentation

Tentatively, global revision knee replacement market has been segmented on the basis of product type, fixation type and end user.

Based on product type, global revision knee replacement market is segmented as below:

• Three compartmental
• Unicompartmental

Based on fixation type, global revision knee replacement market is segmented as below:

• Cemented
• Cementless

Based on end user, global revision knee replacement market is segmented as below:

• Hospitals
• Orthopedic and Prosthetic Clinics
• Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

The global IV infusion gravity bags market was worth US$ 723.8 million in 2022 and is expected to be worth US$ 1281.3 million by 2032, growing at a CAGR of 5.87 percent during the forecast period.

IV infusion gravity bags are adopted for transferring medication straight into intravenous of the patient. IV infusion gravity bags are based on gravitational pull which provides external pressure on the liquid (high height is directly proportional to higher pressure). IV infusion gravity bags are used for fast transport of liquid medication throughout the patient’s body. IV infusion gravity bags are mainly accepted for its use in fluid replacement therapies such as dehydration, electrolyte imbalance, and also for blood transfusion. IV infusion gravity bags range from 50ml to 1000ml.

In addition, IV infusion gravity bags are kept at height by hanging through IV pole. The IV infusion gravity bags mainly comprises of following parts such as drip chamber, roller clamp, slide clamp, and injection port. The working of IV infusion gravity bags are based on gravitational pressure that pushes liquid medication down through tubing/pipe into patient’s veins.

Report Attribute	Details
Estimated Base Year Value (2021)	US$ 684.15 Million
Expected Market Value (2022)	US$ 723.8 Million
Anticipated Forecast Value (2032)	US$ 1281.3 Million
Projected Growth Rate (2022-2032)	5.87% CAGR

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5108

IV Infusion Gravity Bags Market: Drivers and Restraints

The IV infusion gravity bags market shows a healthy growth during the forecast period. The factors such as increasing number chronic disorders and increasing number of surgeries on the global level are driving the growth of IV infusion gravity bags market. In addition, increasing the prevalence of malnutrition and blood transfusion processes in emerging economies are also gardening the market growth of IV infusion gravity bags. However, lack of sophisticated healthcare infrastructure and scarcity of skilled professionals in developing and under-developed regions are hindering the growth of IV infusion gravity bags market.

IV Infusion Gravity Bags Market: Overview

The IV infusion gravity bags carries infusion material for delivering into patient’s vein. The flow of medication through IV infusion gravity bags are controlled by using roller clamp device located on IV pole. IV infusion gravity bags shows a high rate of penetration owing to use in home care settings. With the increasing penetration and ease in availability through the e-commerce website is boosting the growth of IV infusion gravity bags market.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-5108

IV Infusion Gravity Bags Market: Region Wise Outlook

Geographically, IV infusion gravity bags market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is projected to hold the largest share of IV infusion gravity bags in the global market, followed by Western Europe, owing to increasing surgical procedures in this region.

In addition, presence of sophisticated healthcare facility, and rising prevalence of chronic and acute disorders are also gardening the growth of IV infusion gravity bags market. The market in Asia Pacific excluding Japan is anticipated to show the fastest CAGR over the forecast period owing to the presence of large population base and increasing number of hospitals and clinics. However, the market in regions such as Latin America, Eastern Europe, and Middle East and Africa show steady growth over the forecast period.

IV Infusion Gravity Bags Market: Key Players

Some of the market participants in the global IV infusion gravity bags market are Haemotronic Advanced Medical Technologies, Sippex IV Bag, Kraton Corporation, ICU Medical, Inc., Baxter International Inc., Terumo BCT Ltd., The Metrix Company, Renolit, Technoflex, and Bioteque Corporation.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-5108

Key Segments Profiled In The IV Infusion Gravity Bags Market Industry Survey

IV Infusion Gravity Bags by Material type:

• Polypropylene (PP) IV Infusion Gravity Bags
• Polyvinyl Chloride (PVC) IV Infusion Gravity Bags
• Ethylene-Vinyl Acetate (EVA) IV Infusion Gravity Bags
• Low-Density Polyethylene (LDPE) IV Infusion Gravity Bags
• Others

IV Infusion Gravity Bags by Layer Type:

• Single Layer IV Infusion Gravity Bags
• Multiple Layer IV Infusion Gravity Bags

IV Infusion Gravity Bags by End User:

• IV Infusion Gravity Bags for Hospitals
• IV Infusion Gravity Bags for Clinics
• IV Infusion Gravity Bags for Ambulatory surgical Centers
• Others

IV Infusion Gravity Bags by Region:

• North America IV Infusion Gravity Bags Market
• Latin America IV Infusion Gravity Bags Market
• Europe IV Infusion Gravity Bags Market
• Asia Pacific IV Infusion Gravity Bags Market
• MEA IV Infusion Gravity Bags Market

Introduction of upgraded and highly precise lacrimal duct stent tube for canalicular stenosis or obstruction and congenital nasolacrimal duct obstruction remains a key booster to the growth of lacrimal duct stent tube market. The global market for lacrimal duct stent tube is projected for a promising 5.5% CAGR during 2019 – 2029, as suggested by a new Future Market Insights (FMI) report.

There has been higher preference for bicanalicular lacrimal duct stent tube over its monocanalicular counterpart, attributing to the former’s high success rate, suitability for stenting in older patients, and better clinical outcomes. Moreover, increasing prevalence of retina-related conditions, primarily imperforation of nasolacrimal duct, epiphora both in infants and adults, and conditions necessitating dacryocystorhinostomy are other factors responsible for propelling revenue growth of the lacrimal duct stent tube market.

Key Takeaways – Lacrimal Duct Stent Tube Market Study

• Bicanalicular lacrimal duct stent tube is expected to contribute three fourth of revenue share in the lacrimal duct stent tube market owing to its high success rate in stent placement.
• Hospitals captured maximum share of the lacrimal duct stent tube market owing to highest patient footfall followed by ophthalmic clinics.
• Attributed to growing patient pool for retinal diseases, especially due to premature births, contributed to the dominance of North America in the lacrimal duct stent tube market.
• Increasing awareness for availability of the treatment for nasolacrimal duct stent obstruction among caregivers of prematurely born babies and increasing number of skilled professionals are expected to drive growth of the lacrimal duct stent tube market in East Asia.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9649

Manufacturers Emphasizing Advanced Product Development

Numerous organizations are focusing on new product development for lacrimal duct stent tube. In June 2019, FCI Ophthalmic offered a complete line of BIKA stents namely, BIKA, BIKA for DCR, and Infant BIKA covering a range of sizes that will benefit most of the congenital nasolacrimal duct obstruction (CNLDO) and dacryocystorhinostomy (DCR) cases.

Know More About Lacrimal Duct Stent Tube Market Report

Future Market Insights brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each segment from 2014 to 2029. The global lacrimal duct stent tube market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on lacrimal duct stent tube market on basis of product type (monocanalicular lacrimal duct stent tube, bicanalicular lacrimal duct stent tube), and end user (hospitals, ophthalmic clinics, ambulatory surgical centers), across seven major regions.

Key Market Segments Covered In Lacrimal Devices Industry Research

By Product:

• Monocanalicular Lacrimal Duct Stent Tube
• Bicanalicular Lacrimal Duct Stent Tube

 Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-9649

By End User:

• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Global vision screener sales are likely to near US$ 500 Mn by the end of 2022. According to a new research intelligence study presented by Future Market Insights (FMI), the Vision Screeners Market will continue to witness an average 5.9% Y-o-Y growth in the revenues in 2022 and ahead. As reported by the study, more than a third of overall sales of vision screeners is targeted to a variety of vision screening tests, followed by color vision tests.

While portable or handheld vision screening devices have been sought after over the years, it is more likely that the vision screening software will experience rapid gains in coming years, as a result of brisk technological penetration. Moreover, as key manufacturers are investing considerable efforts in technological innovations of vision screeners, table-top variants are also likely to see healthy sales growth in the near future. Currently, more than 50% of the total sales are accounted by portable or handheld devices that are used during vision screening procedures, as per the report.

The rising prevalence of vision problems, advancements in technology, increasing healthcare spending, and the growing prevalence of diabetes constitute some of the key factors responsible for driving the global vision screeners market revenues.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5032

In addition to some of the most commonplace vision disorders, newly establishing problems such as digital eye strain (more popularly, computer vision syndrome) are strongly necessitating the demand for efficient vision screening tests, particularly among the younger population. This, according to FMI’s analysis, will drive sales of vision screeners in the forthcoming years.

Inadequate Effectiveness of Vision Screening Tests Prevails in Developing Asian Markets

Accounting for a collective value share of over 60%, North America and Europe will continue to lead the pack in global vision screeners market. In addition to early adoption of advanced technologies and high awareness about vision problems and the significance of vision screening, the growth of market in these regions has been prominently attributed to the rapid consolidation of healthcare facilities within these regions.

On the other hand, dearth of skilled and trained professionals in the field of vision screening will remain the prime factor restraining vision screeners adoption across developing Asian countries. Relatively lesser competency to professionally and accurately assess vision screening results continues to pose significant barriers in the growth path of market within Asia Pacific (APAC).

According to the report, a sizeable number of vision screening tests cannot be performed on children who have reading problems such as hyperopia or astigmatism. As a result, the ineffectiveness of vision screeners continues to negatively influence the number of parents opting for pediatric vision screening tests, which is further a significant factor deterring the revenues of vision screeners market in APAC.

Pediatric Vision Screening Emerging as a Prime Focus Area for Innovations

Some of the key players competing in the global vision screeners market landscape include Hill-Rom Holdings, Inc. (Welch Allyn), Essilor International S.A. (Stereo Optical Company Inc.), Adaptica S.r.l., OCULUS Surgical, Inc., Plusoptix Inc., Honeywell International Inc., FIM Medical SAS, SHANGHAI TOP VIEW INDUSTRIAL CO., LTD., Thomson Screening Solutions Ltd., and Keystone View. While a majority of these companies are concentrating in technological upgrades of the current offerings, augmented investments targeting FDA approvals will be an important strategy.

 Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-5032

Moreover, multiple longstanding challenges prevailing in children’s vision screening are highly likely to push the scope for innovations, which would help overcome the challenges and extend the efficiency of vision screening – specifically for children. The FMI study reveals how the companies that are manufacturing, supplying, and distributing vision screeners are strategizing on the growing traction in the pediatric patients segment.

Vision Screeners Market by Category

Product:

• Table-Top Vision Screeners
• Portable/Handheld Vision Screeners
• Vision Screening Software

Technology:

• Digital Vision Screeners
• Computer-Based Vision Screeners

Application:

• Vision Screening Tests
• Color Vision Test
• Binocular Testing
• Others

Ask An expert here @ https://www.futuremarketinsights.com/askus/rep-gb-5032

End Users:

• Hospitals
• Homecare Settings
• Specialized Clinics
• Rehabilitation Centers
• Ambulatory Surgical Centers

Region:                    

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific excluding Japan (APEJ)
• Middle East & Africa
• Japan

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The seasonal affective disorder (SAD) therapeutics market is pegged at around US$ 450 million in 2019, with a modest Y-o-Y increase of 3.9% over 2018, according to a recent intelligence report by Future Market Insights. While drugs and devices collectively contribute to the consumption volume of seasonal affective disorder therapeutics, the latter will remain a major shareholder in the market. Towards the end of 2019, more than 3.4 million devices are likely to be sold globally, in seasonal affective disorder therapeutics market.